Dianthus Therapeutics (DNTH) Shares Outstanding (Weighted Average) (2017 - 2025)

Dianthus Therapeutics' Shares Outstanding (Weighted Average) history runs 9 years deep, the most recent figure standing at $43.2 million for Q4 2025.

• In Q4 2025, Shares Outstanding (Weighted Average) rose 29.75% year-over-year to $43.2 million; the TTM figure through Dec 2025 stood at $43.2 million (up 29.75% YoY), while the FY2025 annual figure was $43.2 million, up 29.75% from the prior year.
• Shares Outstanding (Weighted Average) was $43.2 million for Q4 2025 at Dianthus Therapeutics, up from $36.5 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $58.8 million in Q2 2022 to a low of $874234.0 in Q4 2022.
• Historically, Shares Outstanding (Weighted Average) has averaged $29.4 million across 5 years, with a median of $34.6 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Weighted Average) tumbled 98.51% in 2023, then soared 3534.51% in 2024.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $54.9 million in 2021, then slumped by 98.41% to $874234.0 in 2022, then soared by 489.48% to $5.2 million in 2023, then surged by 546.44% to $33.3 million in 2024, then grew by 29.75% to $43.2 million in 2025.
• The last three Shares Outstanding (Weighted Average) figures came in at $43.2 million (Q4 2025), $36.5 million (Q3 2025), and $35.8 million (Q2 2025), per Business Quant data.